Filter Results:
(390)
Show Results For
- All HBS Web
(704)
- People (1)
- News (200)
- Research (390)
- Events (1)
- Multimedia (15)
- Faculty Publications (251)
Show Results For
- All HBS Web
(704)
- People (1)
- News (200)
- Research (390)
- Events (1)
- Multimedia (15)
- Faculty Publications (251)
Sort by
- January 2023
- Case
Thomas Buberl: Refounding AXA
By: Hubert Joly, Mihir Desai and Amram Migdal
In 2022, AXA and its CEO Thomas Buberl faced new types of challenges, including systemic risks such as climate change, geopolitical instability, public health crises, and social tensions caused by economic risks. AXA was one of the world’s largest insurers. Since... View Details
Keywords: Change; Change Management; Transformation; Transition; Trends; Environmental Management; Climate Change; Ethics; Values and Beliefs; Finance; Insurance; Management; Management Succession; Risk Management; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Planning; Strategic Planning; Risk and Uncertainty; Society; Human Needs; Social Issues; Strategy; Adaptation; Business Strategy; Corporate Strategy; Insurance Industry; Europe; France; Paris
Joly, Hubert, Mihir Desai, and Amram Migdal. "Thomas Buberl: Refounding AXA." Harvard Business School Case 523-059, January 2023.
- November 2007
- Case
Antegren: A Beacon of Hope
By: Joshua D. Margolis, Thomas J. DeLong and Terence Heymann
The CEO of Biogen Idec faces a set of difficult decisions regarding a promising drug for Multiple Sclerosis that is headed for early approval by the FDA. The first in a series focuses on operational decisions triggered by the drive for early approval. Sparks discussion... View Details
Keywords: Demand and Consumers; Leadership; Ethics; Corporate Social Responsibility and Impact; Decision Choices and Conditions; Crisis Management; Health Testing and Trials; Biotechnology Industry; Pharmaceutical Industry
Margolis, Joshua D., Thomas J. DeLong, and Terence Heymann. "Antegren: A Beacon of Hope." Harvard Business School Case 408-025, November 2007.
- June 2010 (Revised September 2010)
- Case
athenahealth: Innovating in Response to a Crisis in Healthcare
When Jonathan Bush and his partner, Todd Park, realized that their revolutionary approach to delivering clinical care was being stymied by the inefficiencies in the healthcare system and insurance red tape, they turned their proprietary technology, athenaNet, to a new... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Information Management; Innovation and Invention; Brands and Branding; Product Development; Health Industry; United States
Chakravorti, Bhaskar, Laura Winig, and Naeem Husain Arastu. "athenahealth: Innovating in Response to a Crisis in Healthcare." Harvard Business School Case 810-079, June 2010. (Revised September 2010.)
- January 2015 (Revised July 2019)
- Case
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Case 515-010, January 2015. (Revised July 2019.) (Email mking@hbs.edu for a courtesy copy.)
- December 2016
- Article
Selective Regulator Decoupling and Organizations' Strategic Responses
By: Jonas Heese, Ranjani Krishnan and Frank Moers
Organizations often respond to institutional pressures by symbolically adopting policies and procedures but decoupling them from actual practice. Literature has examined why organizations decouple from regulatory pressures. In this study, we argue that decoupling... View Details
Keywords: Regulator Leniency; Beneficence; Mispricing; Upcoding; Nonprofit Organizations; Health Care and Treatment; Revenue; Health Industry
Heese, Jonas, Ranjani Krishnan, and Frank Moers. "Selective Regulator Decoupling and Organizations' Strategic Responses." Academy of Management Journal 59, no. 6 (December 2016). (Selected for Best Paper Proceedings of the 2015 Academy of Management Annual Meeting. Winner of the Healthcare Management Division of the Academy of Management 2015 Best Paper Award.)
- 15 Mar 2024
- HBS Case
Let's Talk: Why It's Time to Stop Avoiding Taboo Topics at Work
place, discussing one’s next step (or departure) wouldn’t feel abrupt or discriminatory. Health Wing works with a company that saw almost a million dollars in unexpected health care costs last year because... View Details
Keywords: by Avery Forman
- October 2009 (Revised November 2016)
- Case
Generation Health: A Pioneer in Genetics Benefit Management (A)
By: Robert F. Higgins, Jeffrey D. Marrazzo and Rachel Gordon
Generation Health, a pioneer in the new field of genetics benefit management and a newly formed company, faces many strategic issues. CEO Per Lofberg is in the midst of negotiating a partnership with a major pharmacy benefit management company. As part of these... View Details
Keywords: Business Startups; Entrepreneurship; Governing Rules, Regulations, and Reforms; Growth and Development Strategy; Partners and Partnerships; Genetics; Health Industry; Health Industry
Higgins, Robert F., Jeffrey D. Marrazzo, and Rachel Gordon. "Generation Health: A Pioneer in Genetics Benefit Management (A)." Harvard Business School Case 810-007, October 2009. (Revised November 2016.)
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
system and the patients they care for.” The study’s analyses carefully accounted for the recipient practice of the messages and patient characteristics such as age, ZIP code of residence, health status, View Details
- August 2010 (Revised March 2012)
- Case
The UCLA Medical Center: Kidney Transplantation
By: Michael E. Porter, Jennifer F Baron, Jacob Mathew Chacko and Robin Jian Tang
In 2010, organ transplantation remained among the few sets of medical conditions in the U.S. for which bundled payments were a dominant reimbursement model, and for which patient health outcomes were universally measured and reported. In 1986, UCLA Medical Center was... View Details
Keywords: Insurance; Health Care and Treatment; Health Disorders; Measurement and Metrics; Outcome or Result; Competitive Strategy; Integration; Health Industry; California
Porter, Michael E., Jennifer F Baron, Jacob Mathew Chacko, and Robin Jian Tang. "The UCLA Medical Center: Kidney Transplantation." Harvard Business School Case 711-410, August 2010. (Revised March 2012.)
- 30 Jul 2013
- First Look
First Look: July 30
Participation of Disability Insurance Applicants By: Shu, Pian Abstract—Using panel data from the RAND Health and Retirement Study, I show that rejected applicants for Social Security Disability View Details
Keywords: Anna Secino
- 21 Nov 2017
- First Look
First Look at New Research and Ideas, November 21, 2017
others. Our results can help explain a variety of behavioral phenomena including the structure of social insurance programs, patterns of public good provision, and why transactions that turn money into time are often deemed repugnant.... View Details
Keywords: Sean Silverthorne
- 2021
- Book
Management as a Calling: Leading Business, Serving Society
By: Andrew J. Hoffman
Business leaders have tremendous power to influence our society, how it operates, whether it is fair, and the extent to which it impacts the environment. And yet, we do not recognize or call out the responsibility that comes with that power. This book is meant to... View Details
Keywords: Business Education; Power and Influence; Corporate Social Responsibility and Impact; Social Issues; Leadership
Hoffman, Andrew J. Management as a Calling: Leading Business, Serving Society. Stanford University Press, 2021. (Winner of the 2022 PROSE Book Award, Association of American Publishers;
Winner of the 2022 Best Book Award, Social Issues in Management Division, Academy of Management;
Finalist for the 2022 George R. Terry Book Award, Academy of Management.
Chinese Edition: 使命管理, China Science and Technology Press, 2022.)
- 18 Feb 2015
- First Look
First Look: February 18
https://cb.hbsp.harvard.edu/cbmp/product/715411-PDF-ENG Harvard Business School Case 715-423 Discovery Limited Discovery Limited is a South-African based insurance company. Started in the early 1990s, Discovery used behavioral economics... View Details
Keywords: Sean Silverthorne
- 02 Jan 2018
- First Look
First Look at New Research and Ideas, January 3, 2018
Sources of Inefficiency in Health Care By: Chandra, Amitabh, and Douglas O. Staiger Abstract—In medicine, the reasons for variation in treatment rates across hospitals serving similar patients are not well understood. Some interpret this... View Details
Keywords: Sean Silverthorne
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous... View Details
Keywords: DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Health Industry; Health Industry; Health Industry
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
- 14 Feb 2023
- HBS Case
Is Sweden Still 'Sweden'? A Liberal Utopia Grapples with an Identity Crisis
Sweden has long seemed like a social-welfare capitalist dream come true, where companies and labor unions collaborate in harmony with government support. Swedish citizens are among the wealthiest in the world, and they enjoy publicly provided View Details
Keywords: by Lane Lambert
- 12 Apr 2017
- Research & Ideas
Why Productivity Suffers When Employees Are Allowed to Schedule Their Own Tasks
Source: rawpixel Many jobs involve completing a series of sequential, independent, prearranged tasks. Physicians see patients; teachers grade papers; insurance agents process stacks of claims. In the interest of productivity, some... View Details
- December 2021
- Article
Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study
By: Michael Anne Kyle, Renuka Tipirneni, Nitya Thakore, Sneha Dave and Ishani Ganguli
Background
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Primary care practices have experienced major strains during the COVID-19 pandemic, such that patients newly seeking care may face potential barriers to timely visits.
Objective
To quantify availability and wait times for new patient... View Details
Keywords: COVID-19; Ambulatory Care; Policy/economics; Access; Telemedicine; Health Pandemics; Health Care and Treatment
Kyle, Michael Anne, Renuka Tipirneni, Nitya Thakore, Sneha Dave, and Ishani Ganguli. "Primary Care Access During the COVID-19 Pandemic: a Simulated Patient Study." Journal of General Internal Medicine 36, no. 12 (December 2021): 3766–3771.
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- 08 Jan 2019
- First Look
New Research and Ideas, January 8, 2019
to deliver high-quality goods or services in a cost-effective manner. This concept has become increasingly relevant to cardiac catheterization laboratories, as insurers move away from fee-for-service reimbursement and toward payment... View Details
Keywords: Dina Gerdeman